Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.

McKenzie Health celebrated the grand opening of its new Regional Cancer Care and Prevention Center in Watford City on ...

Researchers have uncovered a previously overlooked immune cell that can recognise and kill small cell lung cancer, the most ...

Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted cancer drug offers a superior first-line treatment for aggressive ...

The University of Iowa is opening the state’s first Exercise Oncology Clinic, giving cancer patients statewide free access to ...

A cancer treatment recently approved by the FDA for some pediatric patients is changing the landscape of care for kids.

Ivory Mentz, 8, from Appleton, is regaining her ability to run and play after receiving proton beam therapy for a rare spinal ...